Le SIDA au Ghana (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Molecular Epidemiology of HTLV-II among United States Blood Donors and Intravenous Drug Users: An Age–Cohort Effect for HTLV-II RFLP Type a0

Identifieur interne : 001242 ( Main/Exploration ); précédent : 001241; suivant : 001243

Molecular Epidemiology of HTLV-II among United States Blood Donors and Intravenous Drug Users: An Age–Cohort Effect for HTLV-II RFLP Type a0

Auteurs : Edward L. Murphy ; Renaud Mahieux [France] ; Guy De Thé [France] ; Fredj Tekaia [France] ; Dannie Ameti [États-Unis] ; Jacqueline Horton [États-Unis] ; Antoine Gessain [France]

Source :

RBID : ISTEX:6E7673E1DA630ABB7B43F1C7FD81517561532FDB

Descripteurs français

English descriptors

Abstract

Molecular subtyping was used to investigate the epidemiology of human T-lymphotropic virus type II (HTLV-II) in the United States. Nested polymerase chain reaction of the HTLV-II long terminal repeat region followed by restriction fragment length polymorphism (RFLP) analysis was performed on HTLV-II seropositive subjects including 97 U.S. blood donors without major risk factors for HTLV-II infection, 53 injection drug users (IDU), and 10 American Indian blood donors. Three new HTLV-II RFLP types were confirmed with DNA sequencing and phylogenetic analysis. HTLV-II RFLP type a0 (Switzer classification) was associated with older age [adjusted odds ratio (OR) 1.06 per year of age, 95% confidence interval (CI) 1.02–1.09] and with Black (OR 5.24, 95% CI 1.90–14.47) and White (OR 4.43, 95% CI 1.67–11.75) race/ ethnicity. These data are consistent with an age–cohort effect for HTLV-II RFLP type a0 among older White and Black IDU and blood donors. This finding could be explained by an epidemic of non-a0 HTLV-II RFLP types among younger persons of Hispanic and other race/ethnicity, superimposed upon endemic HTLV-II RFLP type a0 among older Black and White persons.

Url:
DOI: 10.1006/viro.1997.9009


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Molecular Epidemiology of HTLV-II among United States Blood Donors and Intravenous Drug Users: An Age–Cohort Effect for HTLV-II RFLP Type a0</title>
<author>
<name sortKey="Murphy, Edward L" sort="Murphy, Edward L" uniqKey="Murphy E" first="Edward L" last="Murphy">Edward L. Murphy</name>
</author>
<author>
<name sortKey="Mahieux, Renaud" sort="Mahieux, Renaud" uniqKey="Mahieux R" first="Renaud" last="Mahieux">Renaud Mahieux</name>
</author>
<author>
<name sortKey="De The, Guy" sort="De The, Guy" uniqKey="De The G" first="Guy" last="De Thé">Guy De Thé</name>
</author>
<author>
<name sortKey="Tekaia, Fredj" sort="Tekaia, Fredj" uniqKey="Tekaia F" first="Fredj" last="Tekaia">Fredj Tekaia</name>
</author>
<author>
<name sortKey="Ameti, Dannie" sort="Ameti, Dannie" uniqKey="Ameti D" first="Dannie" last="Ameti">Dannie Ameti</name>
</author>
<author>
<name sortKey="Horton, Jacqueline" sort="Horton, Jacqueline" uniqKey="Horton J" first="Jacqueline" last="Horton">Jacqueline Horton</name>
</author>
<author>
<name sortKey="Gessain, Antoine" sort="Gessain, Antoine" uniqKey="Gessain A" first="Antoine" last="Gessain">Antoine Gessain</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6E7673E1DA630ABB7B43F1C7FD81517561532FDB</idno>
<date when="1998" year="1998">1998</date>
<idno type="doi">10.1006/viro.1997.9009</idno>
<idno type="url">https://api.istex.fr/document/6E7673E1DA630ABB7B43F1C7FD81517561532FDB/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000951</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000951</idno>
<idno type="wicri:Area/Istex/Curation">000951</idno>
<idno type="wicri:Area/Istex/Checkpoint">000736</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000736</idno>
<idno type="wicri:doubleKey">0042-6822:1998:Murphy E:molecular:epidemiology:of</idno>
<idno type="wicri:Area/Main/Merge">001339</idno>
<idno type="wicri:Area/Main/Curation">001242</idno>
<idno type="wicri:Area/Main/Exploration">001242</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Molecular Epidemiology of HTLV-II among United States Blood Donors and Intravenous Drug Users: An Age–Cohort Effect for HTLV-II RFLP Type a0</title>
<author>
<name sortKey="Murphy, Edward L" sort="Murphy, Edward L" uniqKey="Murphy E" first="Edward L" last="Murphy">Edward L. Murphy</name>
<affiliation>
<wicri:noCountry code="subField">94143</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Mahieux, Renaud" sort="Mahieux, Renaud" uniqKey="Mahieux R" first="Renaud" last="Mahieux">Renaud Mahieux</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité d'Epidémiologie des Virus Oncogènes, Institut Pasteur, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="De The, Guy" sort="De The, Guy" uniqKey="De The G" first="Guy" last="De Thé">Guy De Thé</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité d'Epidémiologie des Virus Oncogènes, Institut Pasteur, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Tekaia, Fredj" sort="Tekaia, Fredj" uniqKey="Tekaia F" first="Fredj" last="Tekaia">Fredj Tekaia</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Génétique Moléculaire des Levures, Institut Pasteur, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ameti, Dannie" sort="Ameti, Dannie" uniqKey="Ameti D" first="Dannie" last="Ameti">Dannie Ameti</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Westat Inc. Rockville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Horton, Jacqueline" sort="Horton, Jacqueline" uniqKey="Horton J" first="Jacqueline" last="Horton">Jacqueline Horton</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Westat Inc. Rockville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Gessain, Antoine" sort="Gessain, Antoine" uniqKey="Gessain A" first="Antoine" last="Gessain">Antoine Gessain</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité d'Epidémiologie des Virus Oncogènes, Institut Pasteur, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Virology</title>
<title level="j" type="abbrev">YVIRO</title>
<idno type="ISSN">0042-6822</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1998">1998</date>
<biblScope unit="volume">242</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="425">425</biblScope>
<biblScope unit="page" to="434">434</biblScope>
</imprint>
<idno type="ISSN">0042-6822</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0042-6822</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Agarose</term>
<term>American indian</term>
<term>American indian blood donors</term>
<term>American indians</term>
<term>Amerindian</term>
<term>Blood donors</term>
<term>Bootstrap</term>
<term>Bootstrap iterations</term>
<term>Bootstrap values</term>
<term>Cohort</term>
<term>Current study</term>
<term>Defic</term>
<term>Demographic characteristics</term>
<term>Donor</term>
<term>Drug users</term>
<term>Endemic</term>
<term>Epidemiology</term>
<term>Ethidium bromide</term>
<term>Heneine</term>
<term>Hispanic</term>
<term>Human lymphotropic virus type</term>
<term>Human virus type</term>
<term>Immun</term>
<term>Intravenous drug users</term>
<term>Khabbaz</term>
<term>Kimura distance</term>
<term>Long terminal</term>
<term>Lymphotropic</term>
<term>Lymphotropic virus type</term>
<term>Major risk factors</term>
<term>Phylogenetic</term>
<term>Phylogenetic analysis</term>
<term>Phylogroup</term>
<term>Restriction fragment length polymorphism</term>
<term>Retrovir</term>
<term>Retrovirus epidemiology donor study</term>
<term>Rflp</term>
<term>Rflp type</term>
<term>Rflp types</term>
<term>Risk blood donors</term>
<term>Risk factors</term>
<term>Risk subjects</term>
<term>Sexual transmission</term>
<term>Switzer</term>
<term>Syndr</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Agarose</term>
<term>American indian</term>
<term>American indian blood donors</term>
<term>American indians</term>
<term>Amerindian</term>
<term>Blood donors</term>
<term>Bootstrap</term>
<term>Bootstrap iterations</term>
<term>Bootstrap values</term>
<term>Cohort</term>
<term>Current study</term>
<term>Defic</term>
<term>Demographic characteristics</term>
<term>Donor</term>
<term>Drug users</term>
<term>Endemic</term>
<term>Epidemiology</term>
<term>Ethidium bromide</term>
<term>Heneine</term>
<term>Hispanic</term>
<term>Human lymphotropic virus type</term>
<term>Human virus type</term>
<term>Immun</term>
<term>Intravenous drug users</term>
<term>Khabbaz</term>
<term>Kimura distance</term>
<term>Long terminal</term>
<term>Lymphotropic</term>
<term>Lymphotropic virus type</term>
<term>Major risk factors</term>
<term>Phylogenetic</term>
<term>Phylogenetic analysis</term>
<term>Phylogroup</term>
<term>Restriction fragment length polymorphism</term>
<term>Retrovir</term>
<term>Retrovirus epidemiology donor study</term>
<term>Rflp</term>
<term>Rflp type</term>
<term>Rflp types</term>
<term>Risk blood donors</term>
<term>Risk factors</term>
<term>Risk subjects</term>
<term>Sexual transmission</term>
<term>Switzer</term>
<term>Syndr</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>épidémiologie</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Molecular subtyping was used to investigate the epidemiology of human T-lymphotropic virus type II (HTLV-II) in the United States. Nested polymerase chain reaction of the HTLV-II long terminal repeat region followed by restriction fragment length polymorphism (RFLP) analysis was performed on HTLV-II seropositive subjects including 97 U.S. blood donors without major risk factors for HTLV-II infection, 53 injection drug users (IDU), and 10 American Indian blood donors. Three new HTLV-II RFLP types were confirmed with DNA sequencing and phylogenetic analysis. HTLV-II RFLP type a0 (Switzer classification) was associated with older age [adjusted odds ratio (OR) 1.06 per year of age, 95% confidence interval (CI) 1.02–1.09] and with Black (OR 5.24, 95% CI 1.90–14.47) and White (OR 4.43, 95% CI 1.67–11.75) race/ ethnicity. These data are consistent with an age–cohort effect for HTLV-II RFLP type a0 among older White and Black IDU and blood donors. This finding could be explained by an epidemic of non-a0 HTLV-II RFLP types among younger persons of Hispanic and other race/ethnicity, superimposed upon endemic HTLV-II RFLP type a0 among older Black and White persons.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
<li>États-Unis</li>
</country>
<region>
<li>Maryland</li>
<li>Île-de-France</li>
</region>
<settlement>
<li>Paris</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Murphy, Edward L" sort="Murphy, Edward L" uniqKey="Murphy E" first="Edward L" last="Murphy">Edward L. Murphy</name>
</noCountry>
<country name="France">
<region name="Île-de-France">
<name sortKey="Mahieux, Renaud" sort="Mahieux, Renaud" uniqKey="Mahieux R" first="Renaud" last="Mahieux">Renaud Mahieux</name>
</region>
<name sortKey="De The, Guy" sort="De The, Guy" uniqKey="De The G" first="Guy" last="De Thé">Guy De Thé</name>
<name sortKey="Gessain, Antoine" sort="Gessain, Antoine" uniqKey="Gessain A" first="Antoine" last="Gessain">Antoine Gessain</name>
<name sortKey="Tekaia, Fredj" sort="Tekaia, Fredj" uniqKey="Tekaia F" first="Fredj" last="Tekaia">Fredj Tekaia</name>
</country>
<country name="États-Unis">
<region name="Maryland">
<name sortKey="Ameti, Dannie" sort="Ameti, Dannie" uniqKey="Ameti D" first="Dannie" last="Ameti">Dannie Ameti</name>
</region>
<name sortKey="Horton, Jacqueline" sort="Horton, Jacqueline" uniqKey="Horton J" first="Jacqueline" last="Horton">Jacqueline Horton</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001242 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001242 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:6E7673E1DA630ABB7B43F1C7FD81517561532FDB
   |texte=   Molecular Epidemiology of HTLV-II among United States Blood Donors and Intravenous Drug Users: An Age–Cohort Effect for HTLV-II RFLP Type a0
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024